Renal Cell Carcinoma: Clinical Management

ISBN-13: 9781493962655 / Angielski / Miękka / 2016 / 362 str.

Steven C. Campbell; Brian I. Rini

Opis

This valuable clinical resource profiles the new staging system for renal cell carcinoma, reviews fresh data on risk factors, and details new perspectives on renal tumor imaging. It also includes the latest on the molecular biology of metastatic kidney cancer.

Recenzje

From the book reviews:

"Editors S. Campbell and B. Rini, with the support of 40 experts, aimed to come out with an update on recent innovations, focusing on clinical implications. ... A very well-illustrated chapter dealt with various pathological aspects of RCC, including molecular genetics, while another chapter focused on family diseases. ... This textbook offers practical information which is of special interest to all urologists and oncologists involved in RCC management." (European Urology Today, Vol. 25 (3), June-July, 2013)

"This is a concise but comprehensive review of renal cell carcinoma from etiology and risk factors to medical and surgical management. ... This is an excellent resource for any practitioner with an interest in renal cell carcinoma. ... this book would appeal to general oncologists, urologists, general surgeons, radiologists, pathologists, nephrologists, internists, family practitioners, fellows, residents, and students. ... It is thorough, clearly written, and logically presented." (Jean Hoffman-Censits, Doody's Book Reviews, February, 2013)

Spis treści

Section I: Localized Disease

1.      Etiology of RCC: Incidence, Demographics, and Environmental Factors

By Frédéric D. Birkhäuser, MD, Nils Kroeger, MD, and Allan J. Pantuck, MD MS FACS

 

2.      Pathology of Renal Cell Carcinoma

By Ming Zhou, MD PhD, Huiying He

 

3.      Familial Renal Cell Carinoma

By Simon P. Kim, MD, MPH,  Bradley C. Leibovich, MD

 

4.      Imaging of Renal Cell Carcinoma

By Andrei S. Purysko, MD, Erick M. Remer MD, Brian R. Herts, MD

 

5.      Prognostic Factors for Localized Renal Cell Carcinoma

By Brian R. Lane, MD, PhD.

 

Section II: Management of  Localized RCC

 

6.      Assessment of Oncologic Risk for Clinical Stage T1 Renal Tumors and the Emerging Role of Renal Mass BiopsyBy Matthew N. Simmons MD PhD,  Steven C. Campbell MD PhD

 

7.      Radical Nephrectomy for Localized Renal Tumors: Oncological and Renal Functional Considerations

By Paul Russo, MD FACS

 

8.      Nephron-Sparing Surgery for Renal Cancer

By Alon Z. Weizer MD, MS, Jeffery S. Montgomery MD, MHSA, Khaled S. Hafez, MD

 

9.      Thermal Ablation

By Surena F. Matin MD FACS, Kamran Ahrar MD

 

10.  Active Surveillance of the Small Renal Mass

By Marc C. Smaldone, MD, Daniel Canter,  MD, Alexander Kutikov, MD,  Robert G. Uzzo, MD FACS

 

Section III: Locally Advanced Disease

 

11.  Locally Advanced Renal Cell Carcinoma

By Stephen H. Culp, MD PhD, Christopher G. Wood, MD FACS

 

12.  Neoadjuvant Targeted Therapy and Consolidative Surgery

By Sean P. Stroup MD. Ithaar H. Derweesh, MD

 

Section IV: Advanced Disease

 

13.  Biology of RCC (VEGF, mTOR, immune aspects)

By Alexandra Arreola, W. Kimryn Rathmell, MD, PhD

 

14.  Prognostic Factors in Advanced Renal Cell Carcinoma 

By Michael M. Vickers MD, Daniel Y. C. Heng MD MPH

 

15.  Integration of Surgery in Metastatic Renal Cancer

By Tom Powles, MBBS MRCP MD,  Axel Bex, MD

 

16.  Immunotherapy for Renal Cell Carcinoma

By Diwakar Davar, MD,  Moon Fenton, MD, Leonard J Appleman, MD, PhD

 

17.  Targeted Therapy: Vascular Endothelial Growth Factor (VEGF) 

By Linda Cerbone MD, Cora N. Sternberg, MD

 

18.  mTOR in Renal cell carcinoma

By Eric Jonasch, MD, Michel Choueiri, MD

 

19.  Palliative and Supportive Care for Renal Cancer

By Armida Parala-Metz MD, Mellar Davis MD

Blurb

Renal Cell Carcinoma: Clinical Management provides a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians, surgeons and researchers with an interest in kidney cancer. The volume reviews new data about risk factors for the disease, profiles the new staging system for renal cell carcinoma (RCC), highlights our current understanding of familial syndromes of RCC and their molecular genetics, and provides new perspectives about imaging of renal tumors. For localized disease, a greater appreciation of nephron-sparing approaches and the importance of preservation of renal function is discussed in detail. Advances in surgical techniques are highlighted. For metastatic disease, the molecular biology of kidney cancer is reviewed in a concise and understandable manner, including the data that has fostered novel targeted approaches that have revolutionized management. The several landmark phase III targeted therapy trials published in the last few years are placed in context with respect to current management.